Skip to main navigation
Skip to search
Skip to main content
Technical University of Munich Home
Help & FAQ
English
Deutsch
Home
Profiles
Research units
Projects
Research output
Equipment
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
Il2 treatment for cancer: From biology to gene therapy
R. Foa
, A. Guarini
,
B. Gansbacher
Sezione di Clinica Medica
IMM-CNR
Weill Cornell Medical College
Research output
:
Contribution to journal
›
Article
›
peer-review
72
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Il2 treatment for cancer: From biology to gene therapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Acute Myeloid Leukemia
14%
Antitumor
14%
Antitumor Effect
14%
Biological Rationale
14%
Cancer Patients
28%
Clinical Application
14%
Clinical Response
14%
Constitutive Secretion
14%
Cytotoxic Response
14%
Experimental Tumors
14%
Gene Therapy
100%
High Dose
14%
Human Tumor Cells
14%
Innovative Strategies
14%
Interleukin-2
100%
Long-lived
14%
Melanoma
14%
Neoplastic Cells
42%
Renal Cell Carcinoma
14%
Sophisticated Technology
14%
Tumor Cells
14%
Tumor Model
14%
Tumorigenicity
14%
Vaccination Protocols
14%
Medicine and Dentistry
Acute Myeloid Leukemia
14%
Carcinogenicity
14%
Clear Cell Renal Cell Carcinoma
14%
Clinical Finding
14%
Drug Megadose
14%
Experimental Neoplasm
14%
Gene Therapy
100%
Immunotherapy
14%
Infusion
14%
Interleukin 2
100%
Malignant Neoplasm
100%
Melanoma
14%
Secretion (Process)
14%
Tumor
28%
Tumor Cell
28%
Tumor Model
14%
Veterinary Science and Veterinary Medicine
Acute Myelogenous Leukemia
16%
Cancer
100%
Melanoma
16%
Neoplastic Cell
50%
Renal Cell Carcinoma
16%
Tumor
100%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Myeloid Leukemia
14%
Carcinogenicity
14%
Experimental Neoplasm
14%
Immunotherapy
14%
Interleukin 2
100%
Malignant Neoplasm
100%
Melanoma
14%
Renal Cell Carcinoma
14%
Tumor Model
14%